Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

First-line Treatment × trifluridine tipiracil drug combination × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 62 Colonic Neoplasms 13 Rectal Neoplasms 12 Neoplasm Metastasis 10 Stomach Neoplasms 7 Pancreatic Neoplasms 5 Advanced Solid Tumors 5 Gallbladder Neoplasms 3 Colorectal Cancer Metastatic 3 Cholangiocarcinoma 3 Carcinoma 3 Adenocarcinoma 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Carcinoma, Non-Small-Cell Lung 2 Biliary Tract Neoplasms 2 Bile Duct Neoplasms 2 Advanced Solid Tumors (Excluding Breast Cancer) 2 Advanced Colorectal Cancer 2 Adenocarcinoma Of Esophagus 2 mCRC 1 Urologic Diseases 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Spinocerebellar Degenerations 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Sarcoma, Alveolar Soft Part 1 Renal Insufficiency 1 Refractory Solid Tumors 1 Recurrence 1

Interventions

trifluridine tipiracil drug combination 1 lenvatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05077839 2021-10-25

TOBACO

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Unknown

Gastrointestinal

First-line Treatment

Data powered by HemOnc (CC BY 4.0) Colophon ⚡